NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,147,000 | +390.2% | 54,550 | +360.1% | 0.03% | +357.1% |
| Q2 2021 | $234,000 | -33.0% | 11,855 | -1.2% | 0.01% | -36.4% |
| Q1 2021 | $349,000 | -3.9% | 12,000 | 0.0% | 0.01% | -8.3% |
| Q4 2020 | $363,000 | +90.1% | 12,000 | 0.0% | 0.01% | +50.0% |
| Q3 2020 | $191,000 | -25.7% | 12,000 | -7.7% | 0.01% | -38.5% |
| Q2 2020 | $257,000 | +60.6% | 13,000 | 0.0% | 0.01% | +18.2% |
| Q1 2020 | $160,000 | -33.3% | 13,000 | 0.0% | 0.01% | -21.4% |
| Q4 2019 | $240,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $79,175,000 | 44.14% |
| Ponoi II Management, LLC | 1,298,908 | $27,303,000 | 40.46% |
| Column Group LLC | 15,396,116 | $323,626,000 | 36.81% |
| Ponoi Management, LLC | 1,298,908 | $27,303,000 | 24.24% |
| Euclidean Capital LLC | 832,274 | $17,494,000 | 8.50% |
| StepStone Group LP | 1,573,357 | $33,072,000 | 2.14% |
| Octagon Capital Advisors LP | 200,000 | $4,204,000 | 1.04% |
| Redmile Group, LLC | 2,505,118 | $52,658,000 | 0.92% |
| BVF INC/IL | 955,000 | $20,074,000 | 0.78% |
| Boxer Capital, LLC | 500,000 | $10,510,000 | 0.37% |